NP Life Sciences Health Industry Group Inc. (ACAT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 40K 80K 120K Q4 '20: 0 Q2 '22: 15K Q3 '22: 41K Q4 '22: 46K Q1 '23: 30K Q2 '23: 107.1K Q3 '23: 17.5K Q4 '23: 10K Q4 '20 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-50K -25K 0 25K 50K 75K Q1 '22: -31.1K Q2 '22: 1.1K Q3 '22: -5.4K Q4 '22: 16.6K Q1 '23: 1.2K Q2 '23: 71.4K Q3 '23: -37.4K Q4 '23: -35.9K Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Net Income Quarterly

-50K -25K 0 25K 50K 75K Q1 '22: -31.1K Q2 '22: 1.1K Q3 '22: -5.4K Q4 '22: 16.6K Q1 '23: 1.2K Q2 '23: 71.2K Q3 '23: -37.7K Q4 '23: -37.7K Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-80K -40K 0 40K 80K 120K Q1 '22: -4.9K Q2 '22: -22.5K Q3 '22: 6.4K Q4 '22: 114.9K Q1 '23: 18.2K Q2 '23: -37.3K Q3 '23: -40.6K Q4 '23: -13.9K Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '21: 43M Q3 '21: 43M Q1 '22: 43M Q2 '22: 43M Q3 '22: 43M Q1 '23: 43M Q2 '23: 43M Q3 '23: 43M Q2 '21 Q3 '21 Q1 '22 Q2 '22 Q3 '22 Q1 '23 Q2 '23 Q3 '23

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '21 Q1 '22

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.